|
Volumn 174, Issue 12, 2014, Pages 1972-1973
|
Prevention guidelines: Bad process, bad outcome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROCHLOROTHIAZIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LISINOPRIL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
AFRICAN AMERICAN;
BLOOD PRESSURE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
HUMAN;
MEDICAL SOCIETY;
MEDICATION THERAPY MANAGEMENT;
NATIONAL HEALTH ORGANIZATION;
PARTICIPATORY MANAGEMENT;
PRACTICE GUIDELINE;
SECONDARY PREVENTION;
SHORT SURVEY;
CARDIOVASCULAR DISEASES;
FEMALE;
PERCUTANEOUS CORONARY INTERVENTION;
CARDIOVASCULAR DISEASES;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PERCUTANEOUS CORONARY INTERVENTION;
|
EID: 84919485798
PISSN: 21686106
EISSN: 21686114
Source Type: Journal
DOI: 10.1001/jamainternmed.2014.3278 Document Type: Short Survey |
Times cited : (21)
|
References (6)
|